NEW YORK (TheStreet.com) -- CHANGE IN RATINGS
Alpha Natural Resources
reinstated at Barclays with an Overweight rating and $50 price target. Analysts said high-quality coal assets combined with the stability and scale of Foundation's thermal coal production makes a compelling investment opportunity. 2009 EPS estimate cut from $2.10 to $1.75 and 2010 raised from $2.90 to $3.20.
Bed, Bath & Beyond
rated new Buy at Citigroup. $44 price target. Valuation is correlated to square footage growth.
upgraded at Barclays from Equal Weight to Overweight on larger customer base and EPS benefits from cost cutting. 2010 and 2011 EPS estimates raised to $3.36 from $3.00 and to $4.10 from $3.46, respectively. Price target lifted to $64 from $48.
upgraded at Goldman to Neutral from Sell and increased the price target to $75 from $65. Analysts said M&A potentially improving and Greenhill stands to benefit from this trend more than peers. 2010 and 2011 EPS estimates increased to $3.20 from $3.00 and to $4.00 from $3.40.
upgraded at UBS. Rating raised to Neutral from Sell. Price target raised to $16 from $14. Maintains 2009 EPS estimates of $0.68.
upgraded at UBS. Rating raised to Neutral from Sell. Price target raised to $17.00 from $15.50. Maintains 2009 EPS estimates of $0.61.
upgraded at Barclays to Overweight from Equal Weight on belief that the bottom of the cl-alkali cycle has been reached. 2009 EPS estimate raised to $0.83 from $0.52 and 2010 set at $0.51. Price target surged from $11 to $22.
upgraded at Credit Suisse to Outperform from Neutral and boosted the price target to $54 from $42. Based on higher growth and lower costs as displayed in 2Q results. 2009 and 2010 EPS estimates raised to -$0.38 from -$0.91 and to $1.36 from $0.66, respectively.
rated new Buy at Citigroup. $21 price target. Company has upside earnings potential, based on expected margin recovery.
STOCK COMMENTS / EPS CHANGES
price target lifted at Merrill/BofA to $11 from $10. A completed $181mn equity raise strengthens ability to tap attractive opportunities. 2009 EPS estimate drops to $1.35 from $1.39 but 2010 increases to $1.48 from $1.30. Reiterate Buy rating.
numbers increased at UBS through 2010. Company is cutting costs and currency trends should improve. Neutral rating and new $32 price target.
target, estimates increased at Morgan Stanley to $57 from $52 as traffic continues to accelerate. 2010 and 2011 EPS estimates boosted to $3.38 from $3.08 and to $3.80 from $3.46. Maintain Overweight rating.
estimates upped at Citigroup through 2011. Company to see high in-licensing proceeds from Fortesta. Buy rating and $27 price target.
target, estimates changed at Goldman to $28 from $22. 2009 EPS estimate lowered to $0.62 from $0.65 and 2010 EPS estimate raised to $1.40 from $1.20. Maintain Neutral rating.
estimates, target raised at Credit Suisse. Shares now seen reaching $43. Estimates also increased, based on higher realized sales and margins. Outperform rating.
price target lifted at Barclays to $36 from $31 after a well executed 2Q. 2009 and 2010 EPS estimates raised to $2.15 from $1.88 and to $2.40 from $2.20, respectively. Maintain Equal Weight rating.
numbers boosted at Deutsche. Shares now seen reaching $28. Estimates also raised to reflect better containerboard and uncoated paper pricing. Buy rating.
( MEE) price target lifted at Merrill/BofA to $32 from $25, driven by higher met coal pricing and higher target multiples. 2009 EPS estimate set at $0.90 and 2010 increased $0.20 to $1.70. Maintain Neural rating.
target, estimates inflated at Morgan Stanley to $41 from $29 after a solid 2Q displayed a more attractive growth profile. 2009, 2010, and 2011 EPS estimates jumped to $2.25/$2.45/$2.71 from $2.00/$2.19/$2.44. Reiterate Equal Weight rating.
2010 EPS estimate lowered at Morgan Stanley from $4.40 to $4.10. Maintain 2009 and 2011 EPS estimate of $4.40 and $5.25, respectively. Reiterate Overweight rating and $104 price target.
This article was written by a staff member of TheStreet.com.